Documented path
Born in Virginia and raised in Georgia, Bargmann studied biochemistry at the University of Georgia before joining Robert Weinberg's lab at MIT, where she cloned the HER2 oncogene as a graduate student, a finding that directly led to the targeted cancer therapy Herceptin.
Born in Virginia in 1961 and raised in Athens, Georgia; attended the University of Georgia for undergraduate studies in biochemistry.
Torsten N. Wiesel Professor at Rockefeller University; Head of the Wang Laboratory of Neural Circuits and Behavior; Howard Hughes Medical Institute investigator; Head of Science at Chan Zuckerberg Initiative.
Where the conditions came from
Each is placed on a −1 to 3 scale from documented evidence, and the three are never added together. A combined total would rank Cornelia Bargmann against other people. Held apart, they explain why this path ran differently from another one—which is the only comparison this project supports.
The marble itself
+1Tailwind
What capability, drive, or early skill is documented in the person rather than their surroundings?
First Honor Graduate at University of Georgia (top of class). Worked in chemistry and biology labs from a young age. Hid in chemistry lab during pep rallies. Good student in an 'insanely overeducated family' but no prodigy indicators, Olympiad medals, or early acceleration.
Where it was dropped
+2Tailwind
What money, family standing, network, or permission was already in place before the work began?
Father was a professor of statistics and computer science at University of Georgia (previously at IBM Watson Research Center). Mother was a translator. Grew up in 'insanely overeducated household' — oldest sister became English professor, next sister professor of medicine, youngest sister federal public defender. German immigrant family with deep academic values.
The shape of the track
+2Tailwind
What place, timing, institution, or peer group made the next step available?
University of Georgia (worked with bacterial geneticist Sidney Kushner), then MIT PhD in Robert Weinberg's lab at the Whitehead Institute — where she cloned the HER2 oncogene. Postdoc under Robert Horvitz (Nobel laureate). The Weinberg lab at Whitehead was a world-class cancer biology environment.
A −1 is a documented headwind, not a missing value; a 0 means the sources record nothing notable either way. Annotation confidence: High. These are analyst readings of what the sources record, not measurements of merit, talent, or effort. The twenty-two scored dimensions remain available inside the deeper research detail.
What moved through the conditions
Silence in a biography is not evidence that perseverance was absent.
A successful-only archive cannot recover all encounters, avoided setbacks, or alternative outcomes.
Strongest documented signals: Elite institution pipeline, Dedicated mentor / coach, Frontier geography.
Describes the starting position, not what the person later made of it.
Strongest observed levers: Scarce skill depth, Elite ecosystem network, Concentration intensity.
Measures what was present, not whether it was inherited, earned, self-built, external, or mixed.
The timeline below shows the sequence of work and transitions around the selected early milestone. It is evidence of a path, not proof that every step was necessary.
Legendary or globally iconic career standing. The tier summarizes documented career recognition through the data cutoff—not Cornelia Bargmann's worth or future potential.
Question four · where did the leverage come from?
Each non-zero lever gets a best-supported origin, evidence signals, and confidence. Unresolved is the honest default when the biography cannot distinguish self-built, advantage-enabled, earned, external, or mixed.
One or more documented starting advantages plausibly enabled this lever.
One or more documented starting advantages plausibly enabled this lever.
One or more documented starting advantages plausibly enabled this lever.
One or more documented starting advantages plausibly enabled this lever.
One or more documented starting advantages plausibly enabled this lever.
A structural wave is external to the person, even when their position improved access to it.
One or more documented starting advantages plausibly enabled this lever.
This is a bounded inference from the current annotations—not a claim about private effort, merit, or the percentage of Cornelia Bargmann's outcome attributable to any origin.
Structural luck, Encounter luck, Event luck, Outcome variance can change every arrow in the path. This successful-only dataset cannot observe the near-identical paths that did not break through, so luck stays visible and unscored.
Multiplying capacity documented later in the path. Measures what was present, not whether it was inherited, earned, self-built, external, or mixed.
Access or conditions documented near the beginning of the path. Zero means "no clear evidence in reviewed sources," not "advantage was absent."
Born in 1961 in Virginia and raised in Athens, Georgia; not much is documented about her family's financial status in reviewed sources.
Not documented in reviewed sources.
Bargmann grew up in Athens, Georgia, and studied biochemistry at the University of Georgia before joining Robert Weinberg's lab at MIT's Whitehead Institute. As a PhD student, she cloned the neu/HER2 oncogene, demonstrating it encoded a receptor tyrosine kinase. This work directly led to the development of Herceptin, a targeted breast cancer therapy. The MIT/Whitehead ecosystem and Weinberg's mentorship were crucial.
advantage confidence: High · source count: 3 · audit: source_verified · status: subagent_researched_beta